India Pediatric Drugs and Vaccines Market Outlook to 2021 : Ken Research

Ken Research Latest report on “India Pediatric Drugs and Vaccines Market Outlook to 2021– Rise in prevalence of chronic diseases and inclusion of several new vaccines in national immunization programme to Shape Future Growth” provides a comprehensive analysis of the pediatric drugs and vaccines market in India and covers market size and segmentation of overall market by drugs and vaccines. The report covers the further segmentations of different spaces such as Drugs and Vaccines into sub segments based on their individual characteristics. The sub segments of Drugs (Patented and Generic, Treatment and Management, Drug Classes, Prescription and OTC, Online and Offline) are then considered separately and analysis on them has been done individually. Similarly, the sub segments of Vaccines (Monovalent and Multivalent, Technology, Indication) have also been considered. The report covers detailed profiles of leading players in the different sub segments in the market. The potential and future outlook has been individually discussed for India Pediatric Drug and Vaccine market. The report provides detailed analysis of segments, trends & developments, growth drivers and major restraints and challenges within the industry. The report also serves as a benchmark for existing players and for new players who wish to capitalize on the market potential and investors who are looking forward to venture into pediatric drugs and vaccines market in India.

India Pediatric Drugs Market

India is a home of the largest pediatric population of the world and also has the highest number of annual child births in the world. However, almost ~% of the medicines used in children presently has never been studied for their efficacy in pediatric population. The pediatric drugs market in India grew at a staggering CAGR of ~% during the period FY’2011-FY’2016 exhibiting the annual revenue of INR ~ billion in FY’2011 which inclined to INR ~ billion in FY’2016. Owing to an astounding number of births in the country, the pediatric drugs market has showcased growth at a faster pace than the overall pharmaceutical market of the country during the concerned period.

Segmentation

By Product Type (Patented and Generic): The market for pediatric drugs and vaccines in India is entirely driven by companies manufacturing generic drug formulations. Almost all pharmaceutical companies operating in the country have expertise in developing generic drugs so as to cater to the underprivileged population at a much cheaper price. Generic drug therefore comprised almost ~% of the market share as of FY’2016 whereas patented drugs accounted for ~% market share.

By Usage (Treatment and Management): A large part of drugs sold in the country is meant for the treatment of several infectious and non-infectious diseases prevalent in the pediatric population. Pediatric drugs are most commonly used for diarrheal diseases such as cholera and viral gastroenteritis. Owing to less prevalence of lifestyle diseases amongst pediatric population, market share of drugs meant for management of diseases has been low. Drugs meant for management of diseases accounted for ~% market share as compared to ~% for treatment of diseases.

By Drug Classes (Anti-Infectives, Antihistamines, Cardiovascular Drugs and Others): Anti-infectives were the most frequently prescribed drug class by pediatricians, with over ~% of the prescriptions had some form of prescribed antibiotics. This was due to wide scale prevalence of respiratory diseases among children. Anti-infectives accounted for a market share of ~% as of FY’2016 as compared to anti-histamines (~%), cardiovascular drugs (~%) and all other (~%) categories of drugs.

By Procurement Method (Prescription and OTC): In India, parents always consult a doctor for their children’s illness and therefore only buy drugs that are prescribed by a healthcare professional. Scenario is same in both rural and urban areas as parents are very conscious about children’s well being and are not willing to rely on OTC drugs without proper knowledge and supervision. Prescription drugs therefore contributed to around ~% in market share as compared to ~% by OTC drug as of FY’2016.

By Distribution Channel (Online and Offline): Currently, procurement of pediatric drugs is almost entirely done through offline medium from hospital pharmacies, retail pharmacies, doctors or institutional health centers. Since the requirement of drugs is usually on an urgent basis, parents don’t prefer placing an order online and receive it a later date. As a result, offline sales of drugs accounted for almost ~% of the drug sales as compared to ~% by online medium.

India Pediatric Vaccines Market

India has emerged as the leading vaccine producer in the world, in terms of doses of vaccines produced. The country has ~ major vaccine manufacturing facilities across the country as of FY’2016. Vaccines manufactured in these facilities are offered in both national and international market (over 150 countries). More than ~% of all measles vaccines used globally are produced in India.

The Indian pediatric market for vaccines has grown at a remarkable CAGR of ~% during the period FY’2011-FY’2016. The growth was attributed to some crucial vaccines (polio, hepatitis B, MMR and BCG) manufactured by Indian companies constantly featured in WHO’s prequalified list coupled with the fact that Indian companies (Serum Institute of India, Bharat Biotech, Panacea Biotec) acted as major suppliers of vaccines to WHO, UNICEF, PATH and other UN agencies. The market for pediatric vaccines grew from INR ~ billion in FY’2011 to INR ~ billion in FY’2016.

Segmentation

By Type of Vaccine A large chunk of vaccines administered under the national immunization programme in the country are of the monovalent form. Monovalent vaccines therefore comprised for a market share of ~% as compared to ~% by multivalent forms.

By Technology: Inactivated vaccines were the earliest forms of vaccines developed by scientists and continue to be widely used in the country. Killed or inactivated vaccine comprised a market share of ~% as compared to ~% by live or attenuated, ~% by toxoid vaccines, ~% by subunit forms, ~% by conjugate vaccines and remaining ~% by all other forms.

Key Topics Covered in the Report:

Value Chain Analysis of India Pediatric Drugs and Vaccine Market
India Pediatric Drugs and Vaccine Market by Value, FY’2011-FY’2016
India Pediatric Drugs Market Introduction and Size, FY’2011-FY’2016
India Pediatric Drugs Market Segmentation by Product Type (Patented and Generic), by Usage (Treatment and Management), by Drug Classes (Anti-infectives, Antihistamines, Cardiovascular drugs and Others), by Procurement Method (Prescription and OTC), by Distribution Channel (Offline and Online), FY’2016
Competitive Landscape of Major Players in India Pediatric Drugs Market
India Pediatric Drugs Future Market Outlook, FY’2017-FY’2021
India Pediatric Vaccines Market introduction and Size, FY’2011-FY’2016
India Pediatric Vaccines Market Segmentation by Vaccine Type (Monovalent and Multivalent), by Technology (Live or attenuated, Killed or inactivated, Toxoid, Conjugate, Subunit and Others), by Indication (Polio, MMR, DTP, Hepatitis B, Influenza, BCG and Others), FY’2016
Competitive Landscape of Major Players in India Pediatric Vaccines Market
Pipeline Analysis of Global and India Pediatric Vaccine Market
India Pediatric Vaccines Future Market Outlook, FY’2017-FY’2021